AnaptysBio, Inc.
MX ˙ BMV ˙ US0327241065
SecurityMX:ANAB / AnaptysBio, Inc.
InstitutionSei Investments Co
Latest Disclosed Ownership4,966 shares
Latest Disclosed Value $ 240,752
Sei Investments Co reports 66.72% decrease in ownership of ANAB / AnaptysBio, Inc.

On February 13, 2026 - Sei Investments Co filed a 13F-HR form disclosing ownership of 4,966 shares of AnaptysBio, Inc. (MX:ANAB) valued at $240,752 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 13, 2025 disclosing 14,921 shares of AnaptysBio, Inc.. This represents a change in shares of -66.72% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F ANAPTYSBIO COM 032724106 4,966 -9,955 -66.72 241 -47.37 0.0002
2025-11-13 2025-09-30 13F ANAPTYSBIO COM 032724106 14,921 14,921 457 0.0005
2022-05-13 2022-03-31 13F ANAPTYSBIO COM 032724106 0 -7,871 -100.00 0 -100.00
2022-02-14 2021-12-31 13F ANAPTYSBIO COM 032724106 7,871 36 0.46 273 28.77 0.0005
2021-11-12 2021-09-30 13F ANAPTYSBIO COM 032724106 7,835 7,835 212 0.0004
2020-12-04 2020-09-30 13F/A-1 ANAPTYSBIO COM 032724106 0 -23,853 -100.00 0 -100.00
2020-08-17 2020-06-30 13F/A-1 ANAPTYSBIO COM 032724106 23,853 23,853 533 0.0017
2020-02-06 2019-12-31 13F ANAPTYSBIO COM 032724106 0 -9,483 -100.00 0 -100.00
2019-11-12 2019-09-30 13F ANAPTYSBIO COM 032724106 9,483 0 0.00 332 -37.94 0.0008
2019-08-14 2019-06-30 13F ANAPTYSBIO COM 032724106 9,483 -1,688 -15.11 535 -34.44 0.0017
2019-05-15 2019-03-31 13F ANAPTYSBIO COM 032724106 11,171 187 1.70 816 -25.55 0.0027
2019-02-13 2018-12-31 13F ANAPTYSBIO COM 032724106 10,984 0 0.00 1,096 0.00 0.0039
2018-11-08 2018-09-30 13F ANAPTYSBIO COM 032724106 10,984 0 0.00 1,096 40.51 0.0040
2018-08-03 2018-06-30 13F ANAPTYSBIO COM 032724106 10,984 10,984 780 0.0027
2018-05-11 2018-03-31 13F ANAPTYSBIO COM 032724106 0 -4,688 -100.00 0 -100.00
2018-02-08 2017-12-31 13F ANAPTYSBIO COM 032724106 4,688 4,688 472 0.0016
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.